Literature DB >> 1831514

[Enhanced myocardial depression from bupivacaine in diabetic rats].

M Imai1, K S Chang, R D Tanz, W C Stevens, O Kemmotsu.   

Abstract

We examined the direct effects of bupivacaine on the diabetic rat myocardium using an isolated perfused (Langendorff) heart preparation. Rats were made diabetic by injection of streptozotocin (55 mg.kg-1, i. v.). 12 weeks after the administration of streptozotocin, hearts were excised and perfused using Langendorff technique. Following 60 min for equilibration, diabetic hearts from the 12-week animals exhibited significant bradycardia. Bupivacaine 3 mcg.ml-1 did not decrease myocardial contractility in control animals. However, 3 mcg.ml-1 bupivacaine decreased contractility significantly in diabetic animals at nearly all periods. Bupivacaine decreased heart rate and coronary flow significantly and similarly in control and diabetic rats hearts. After pacing at 4 Hz, bupivacaine decreased contractility more in diabetic group than in control group. These results indicate that the presence of a diabetic state appears to enhance the sensitivity of the heart to the myocardial depressant effect of bupivacaine.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1831514

Source DB:  PubMed          Journal:  Masui        ISSN: 0021-4892


  2 in total

1.  A cardiovascular collapse during cemented total hip replacement in a diabetic patient.

Authors:  M Imai; Y Hanaoka; K Sugawara; F Murakami; C Matsumura; O Kemmotsu
Journal:  J Anesth       Date:  1992-04       Impact factor: 2.078

2.  Insulin Signaling in Bupivacaine-induced Cardiac Toxicity: Sensitization during Recovery and Potentiation by Lipid Emulsion.

Authors:  Michael R Fettiplace; Katarzyna Kowal; Richard Ripper; Alexandria Young; Kinga Lis; Israel Rubinstein; Marcelo Bonini; Richard Minshall; Guy Weinberg
Journal:  Anesthesiology       Date:  2016-02       Impact factor: 7.892

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.